Answers are grounded in this paper and cite their sources.
Demonstrates that captopril normalizes blood pressure and alleviates cardiac inflammation in hypertensive rats, suggesting cardioprotection mediated by NF-kB inhibition.
Objectives: To investigate the effects of captopril (an inhibitor of the angiotensin converting enzyme,ACE) on the inflammatory process that accompanies arterial hypertension, and to evaluate possible mechanisms of action of captopril as a cardioprotective drug in the hypertensive process. Design and Methods: We used four groups of rats: 1) Wistar- Kyoto (WKY) rats, as a control group; (2) Spontaneously Hypertensive Rats (SHR); (3) WKY rats treated with captopril, and (4) SHR treated with captopril. The treatment consisted of an oral dose of 80 mg per kg of body weight per day, and was maintained for 12 weeks. After this period, blood and hearth samples were obtained to determine the serum levels and gene expression (by real-time PCR) of the inflammatory markers, namely interleukin-β (IL-β) and IL-6. In addition, we measured the gene expression of ACE, angiotensin II receptor 1 (AT1 receptor), and the NF-k°B/Ik°B system, in order to evaluate the role of this transcription factor in captopril-mediated effects. Results: The chronic administration of captopril resulted in a complete normalization of diastolic and systolic blood pressure values in hypertensive rats. The same results were obtained with regard to the relative hearth weight. The serum levels of IL-β and IL-6, which were also elevated in SHR, returned to normal after treatment with captopril, too. IL-β and IL-6 mRNA expression, which was significantly higher in hypertensive than in control rats, decreased after the treatment. In addition, higher expression of ACE, AT1 receptor and NF- kB, and lower expression of the inhibitory subunit IkB, was measured in hypertensive animals, all these alterations being corrected after captopril administration. On the other hand, no effects were observed in captopril-treated normotensive (WKY) rats. Conclusions: Our study shows anti-inflammatory and cardioprotective effects of captopril in arterial hypertension, since this drug was able to decrease the amount of pro-inflammatory cytokines at both systemic and cardiac levels. This cardioprotective role of captopril is mediated by inhibitory actions on the renin-angiotensin system and the transcription factor NF-kB.
No takes yet. Share an insight, caveat, or question.
Sevilla et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: